Showing results (431-440 of 458) with videos related to

Sort By:
Pageof 46
Anticancer Research|April 3, 2014
New possibilities in hepatocellular carcinoma treatmentMahmood Rasool, Sana Rashid, Mahwish Arooj, et al.
Parkinsonism & Related Disorders|May 18, 2023
Autosomal dominant Parkinson's disease caused by the recently identified LRRK2 N1437D mutation in a Chinese family: Clinical features, imaging findings, and functional impactYi-Min Sun, Lin-Hua Gan, Fang Peng, et al.
Molecules (Basel, Switzerland)|May 14, 2022
In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and TherapyCharles Gnanaraj, Mahendran Sekar, Shivkanya Fuloria, et al.
Drug Design, Development and Therapy|November 12, 2021
Chemistry, Biosynthesis, Physicochemical and Biological Properties of Rubiadin: A Promising Natural Anthraquinone for New Drug Discovery and DevelopmentMohd Nasarudin Watroly, Mahendran Sekar, Shivkanya Fuloria, et al.
Archiv Der Pharmazie|November 20, 2022
Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutationOnur Bender, Mai E Shoman, Taha F S Ali, et al.
Foods (Basel, Switzerland)|September 28, 2021
Comparison of Nutritional Knowledge, Attitudes and Practices between Urban and Rural Secondary School Students: A Cross-Sectional Study in Sabah, East MalaysiaMohammad Halim Bin Jeinie, Rhanye Mac Guad, Marion M Hetherington, et al.
Frontiers in Pharmacology|May 20, 2021
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 TherapiesMurtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Antibacterial Potential of <i>Bacopa monnieri</i> (L.) Wettst. and Its Bioactive Molecules against Uropathogens-An In Silico Study to Identify Potential Lead Molecule(s) for the Development of New Drugs to Treat Urinary Tract InfectionsJyoti Mehta, Kumar Utkarsh, Shivkanya Fuloria, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular DisordersFarrah Syazana Khattulanuar, Mahendran Sekar, Shivkanya Fuloria, et al.
Molecules (Basel, Switzerland)|February 15, 2022
Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for InflammationNaurah Nabihah Nasir, Mahendran Sekar, Shivkanya Fuloria, et al.
Pageof 46